（原标题：机器人、低空持续火热，一星机器人种子轮融资数亿元｜投融资周报） 一句话趋势：具身智能持续火热，低空经济备受关注，芯片与半导体赛道热度不减。 过去一周披露的投融资案例显示，科技与制造行业依旧是资本关注重点，低空经济赛道备受青睐。微分智飞（杭州）科技有限公司连续完成两亿 元Pre-A轮和Pre-A+轮融资，其中，Pre-A轮融资由东方富海、洪泰基金领投，雅瑞资本跟投；Pre-A+轮由华映资本领投，深创投、尚颀资本、长 石资本跟投。 消费服务 医疗健康领域，生物医药依然表现稳健，大额融资方面，北京华龛生物科技有限公司宣布完成数亿元B+轮融资，本轮融资汇聚多家头部投资机 构，包括北京市医药健康产业投资基金、北京市新材料产业投资基金、工融顺禧基金、京国瑞基金、国新基金、远至资本、招银国际资本、重庆 向新力基金、国康基金、中关村资本等。 消费服务领域，专注中式汉堡的麒麟燚餐饮管理（成都）有限责任公司宣布完成1860万元A轮融资，由四川智胜资本投资。 21创投不完全统计，9月15日—9月21日，报告日期内国内一级市场发生融资事件24起。其中，有21笔融资披露了融资金额和币种信息，总规模约 合人民币30.496亿元 ...

全球医疗困局倒逼AI变革 当前，全球医疗市场总规模已接近10万亿美元。美国作为最大医疗支出国，2023年卫生总支出突破4.9万亿美元，其中约75%用于服务端。然而，医护资源 短缺问题日益严峻：2023年，16.7%的美国医院预见到关键岗位人力不足，预计到2031年每年需填补超20万个护理职位。与此同时，65岁以上人口已达4600 万，2050年将翻倍至9000万，慢性病与长期护理需求激增。 在政策与市场需求双重驱动下，迈纳士（Minauth）率先推出"基层医疗AI诊断工程"，以"AI+微流控+区块链"技术为核心，打造覆盖县域医共体的智能采检 闭环，破解基层医疗"不可能三角"。公司核心产品——"Magic Lab智能诊断体"已于2025年5月获得国家二类医疗器械注册证，正式进入临床应用阶段。该设 备集自动采血机器人与多功能分析仪于一体，实现从采血、检测到报告生成的全流程自动化，真正构建"一平米检验科"。 另一方面，全流程自动化不仅显著提升效率，更有效避免了传统模式下因人工操作、样本转运带来的误差、延误与污染风险。尤其在标本外送需6小时以上 的偏远地区，迈纳士的采检一体机实现了"即时诊断、即时干预"的突破，大幅提 ...

Group 1: Financing and Investment - ShunJing Pharmaceutical has completed a 300 million RMB Series A financing round, led by multiple investment firms including Songhe Fund and Dacheng Fund [1] - The funds will primarily be used to accelerate the Phase II clinical trials of SGC001, a novel antibody drug for acute myocardial infarction, and other core pipeline IND applications and clinical research [1] - Horizon Robotics has announced a successful 100 million USD Series A financing round, attracting numerous domestic and international investors [2] Group 2: Product Development and Innovation - ShunJing Pharmaceutical focuses on developing first-in-class (FIC) and best-in-class (BIC) drugs, with SGC001 being the fastest in development, having received IND approval from both the FDA and the National Medical Products Administration [1] - The company aims to enhance its strategic layout in the biopharmaceutical industry, aligning with China's 14th Five-Year Plan for biopharmaceutical development [1] - Horizon Robotics has built a complete product system covering chips, algorithms, and software to meet the diverse needs of intelligent robots across various sectors [3] Group 3: Market Expansion and Ecosystem - ShunJing Pharmaceutical's funding is expected to deepen its strategic layout and enhance its long-term operational development [1] - Horizon Robotics is expanding its developer ecosystem, empowering over 200 small and medium-sized creators and incubating nearly 100 new types of intelligent robots [5] - The company has established partnerships with over 200 universities to cultivate talent in the field of intelligent robotics [6] Group 4: Industry Trends and Future Outlook - The financing activities reflect a growing interest in the biopharmaceutical and intelligent robotics sectors, indicating a robust investment climate [2][4] - Companies are increasingly focusing on integrating innovative technologies and expanding their product offerings to capture larger market shares [2][5] - The advancements in intelligent robotics and biopharmaceuticals are expected to contribute significantly to the overall growth of the respective industries in the coming years [1][3]

Core Insights - In May, Tianhu Technology recorded 21 investment and financing events related to technology innovation and entrepreneurship in Chengdu, indicating a vibrant investment landscape in the region [1][3]. Group 1: Investment Events - Chengdu Hailong Aerospace Technology Co., Ltd. completed angel round financing, focusing on the development of star sensors and magnetic moment devices [2][10]. - Chengdu Zhongke Xingchen Information Technology Co., Ltd. secured equity financing, specializing in satellite mobile communication terminals [2][11]. - Chengdu Xinglu Aerospace Technology Co., Ltd. completed equity financing, engaged in satellite technology integration [2][12]. - Sichuan Jushen Humanoid Robot Technology Co., Ltd. raised tens of millions in angel round financing, focusing on humanoid robots [2][13]. - Chengdu Jiuzhang Zhifang Technology Co., Ltd. completed equity financing, providing technology promotion services [2][14]. - Chengdu Annu Intelligent Technology Co., Ltd. raised tens of millions in seed round financing, focusing on humanoid robot applications [2][15]. - Chengdu Chengfa Kenen Power Engineering Co., Ltd. completed A round financing, specializing in industrial power equipment [4]. - Chengdu Chuangyi Micro-Nano Technology Co., Ltd. completed angel round financing, focusing on specialized instrument manufacturing [6]. - Sichuan Blue Ocean Intelligent Equipment Manufacturing Co., Ltd. completed A round financing, specializing in intelligent equipment for underground engineering [7]. - Chengdu Jingzhan Electronic Technology Co., Ltd. completed A round financing, focusing on power semiconductor chip design [8]. - Sichuan Jinlong Microelectronics Technology Co., Ltd. completed A round financing, specializing in MEMS silicon oscillators [9]. - Chengdu Weikang Biotechnology Co., Ltd. completed equity financing, focusing on biotechnology research [17]. - Chengdu Kerry Medical Technology Co., Ltd. completed tens of millions in Pre-A round financing, focusing on intelligent blood collection robots [18]. - Sichuan Tiannuo Juneng New Energy Development Co., Ltd. completed equity financing, focusing on lithium-silicon anode materials [19]. - Chengdu Hangxin Aviation Equipment Technology Co., Ltd. completed equity financing, specializing in aviation parts manufacturing [21]. - Chengdu Xinghan Aerospace Technology Co., Ltd. completed equity financing, focusing on rocket control systems [22]. Group 2: Market Trends - The majority of financing events were in the seed and angel round stages, indicating a focus on early-stage investments [3]. - The digital economy and electronic information sectors were the hottest investment areas in Chengdu, with nearly 30% of projects related to the digital economy and about 25% related to electronic information [3].